IL-33通过ERK介导上皮间质转化促进特发性炎性肌病相关间质性肺病
该研究整合人IIM-ILD样本与MAILD小鼠模型,发现血清及肺组织IL-33升高,IL-33敲除减轻肺炎症与纤维化,外源IL-33恢复ILD严重度;ERK抑制剂U0126减轻p-ERK、EMT及肺损伤,提示IL-33/ERK轴为潜在治疗靶点。
要点
- IIM-ILD患者血清IL-33较健康对照显著升高,肺组织IL-33同步上调。
- IL-33敲除MAILD小鼠肺炎症减轻、肺泡结构改善、胶原沉积减少。
- U0126抑制p-ERK并抑制EMT,改善MAILD小鼠肺炎症与纤维化。
核心结论
- IL-33通过激活ERK介导的EMT促进IIM-ILD进展,IL-33/ERK信号轴为潜在治疗靶点。
研究设计与样本
- 整合人IIM-ILD样本分析与采用IL-33敲除及重建策略的MAILD小鼠模型研究。
- 体内使用U0126抑制ERK通路;体外用NETs刺激IL-33敲低肺泡上皮细胞。
- 评估方法包括ELISA、免疫组化/免疫荧光、Western blot和RNA测序。
主要发现
- IIM-ILD患者血清IL-33较健康对照显著升高,肺组织IL-33同步上调。
- MAILD小鼠IL-33表达升高;IL-33敲除小鼠肺炎症减轻、肺泡结构改善、胶原沉积减少。
- 外源IL-33使IL-33敲除小鼠ILD严重度恢复至野生型水平。
- p-ERK及EMT标志物(E-Ca和α-SMA)水平与IL-33表达相关。
- U0126降低p-ERK、抑制EMT并改善肺炎症与纤维化;体外NETs诱导A549细胞EMT和ERK激活,IL-33沉默后该效应消失。
临床怎么用
- IL-33/ERK信号轴被识别为IIM-ILD的潜在治疗靶点,支持精准干预的转化策略。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Interstitial lung disease (ILD) is the most common and prognostically severe complication of idiopathic inflammatory myopathy (IIM), for which targeted treatments remain limited. Based on previous findings that neutrophil extracellular traps (NETs) are key mediators in IIM-ILD pathogenesis and given the established role of interleukin-33 (IL-33) in promoting NETosis, we hypothesized. METHODS: We integrated analyses of human IIM-ILD samples with a myositis-associated ILD (MAILD) mouse model employing IL-33 knockout (KO) and reconstitution strategies. The ERK pathway was inhibited in vivo with U0126. In vitro, IL-33 knockdown alveolar epithelial cells were challenged with NETs. Assessments included enzyme-linked immunosorbent assay, immunohistochemistry and/or immunofluorescence, Western blot, and RNA sequencing. RESULTS: Serum IL-33 levels were significantly elevated in patients with IIM-ILD compared with healthy controls, with concurrent upregulation of IL-33 in lung tissues. MAILD mice similarly showed increased IL-33 expression, whereas IL-33 KO mice exhibited attenuated lung inflammation, improved alveolar architecture, and decreased collagen deposition. Administration of exogenous IL-33 restored ILD severity in IL-33 KO mice to wild-type levels. The levels of p-ERK and epithelial-mesenchymal transition (EMT) markers (E-Ca and α-smooth muscle actin) correlated with IL-33 expression. U0126 reduced p-ERK levels, suppressed EMT, and ameliorated both pulmonary inflammation and fibrosis. In vitro, NETs induced EMT and ERK activation in A549 cells, effects that were abolished upon IL-33 silencing. CONCLUSIONS: IL-33 promotes IIM-ILD progression by activating ERK-mediate EMT, identifying the IL-33/ERK signaling axis as a potential therapeutic target. These results provide mechanistic insight into IIM-ILD pathogenesis and support translational strategies for precision intervention.
引用
- Yang J, Li W, Zhu J, et al. Interleukin-33 Promotes Interstitial Lung Disease in Idiopathic Inflammatory Myopathy Via ERK-Mediated Epithelial-Mesenchymal Transition: ERK as a Potential Therapeutic Target. Arthritis Rheumatol. 2026. PMID: 41288093. doi:10.1002/art.43453
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。